News and Announcements
Episode 300 with Ludwina Dautovic, The Room Exhange
- Published February 22, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Social Geek Radio hosts Deb Evans and Jack Monson celebrate Social Geek Radio’s 300th episode with their guest from Australia, Ludwina Dautovic, Founder and CEO, The Room XChange.
The Room Xchange, a service which connects busy professionals and empty nesters with a spare room in their home (hosts) with travelers and guests who provide an agreed amount of help around the home in exchange for food and accommodation.
To Listen please click below.
Company Updates
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
Backed By Leading Investment Groups and Family Offices
